Corronarobetin en es it fr

Corronarobetin Brand names, Corronarobetin Analogs

Corronarobetin Brand Names Mixture

  • No information avaliable

Corronarobetin Chemical_Formula


Corronarobetin RX_link

Corronarobetin fda sheet

Corronarobetin FDA

Corronarobetin msds (material safety sheet)

Corronarobetin Synthesis Reference

No information avaliable

Corronarobetin Molecular Weight

387.711 g/mol

Corronarobetin Melting Point

No information avaliable

Corronarobetin H2O Solubility

No information avaliable

Corronarobetin State


Corronarobetin LogP


Corronarobetin Dosage Forms

Cream; Ointment; Suppository (each applicator-full provides approximately 4.6 grams of ointment containing 300 mg of tioconazole)

Corronarobetin Indication

For the local treatment of vulvovaginal candidiasis (moniliasis).

Corronarobetin Pharmacology

Tioconazole is a broad-spectrum imidazole antifungal agent that inhibits the growth of human pathogenic yeasts. Tioconazole exhibits fungicidal activity in vitro against Candida albicans, other species of the genus Candida, and against Torulopsis glabrata. Tioconazole prevents the growth and function of some fungal organisms by interfering with the production of substances needed to preserve the cell membrane. This drug is effective only for infections caused by fungal organisms. It will not work for bacterial or viral infections.

Corronarobetin Absorption

Systemic absorption following a single intravaginal application of tioconazole in nonpregnant patients is negligible.

Corronarobetin side effects and Toxicity

Symptoms of overdose include erythema, stinging, blistering, peeling, edema, pruritus, urticaria, burning,

Corronarobetin Patient Information

Corronarobetin Organisms Affected

Yeast and other fungi